Kezdőlap › Hólyagrák › Massachusetts › Boston
Hólyagrák klinikai vizsgálatok: Boston, MA
26 Hólyagrák vizsgálat keres résztvevőket Boston és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Toborzás folyamatban3. fázis
- Brigham and Women's Hospital, Boston
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Toborzás folyamatban2. fázis
- Massachusetts General Hospital Cancer Center, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Toborzás folyamatban2. fázis
- Dana-Farber Cancer Institute - Oncology Department, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Toborzás folyamatban2. fázis
- Tufts Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Patient-Centered Surgical Prehabilitation
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Toborzás folyamatban3. fázis
- Dana Farber Cancer Institute ( Site 0783), Boston
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Toborzás folyamatban3. fázis
- Massachusetts General Hospital, Boston
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy
Toborzás folyamatban
- Dana Farber Cancer Institute, Boston
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Dana-Farber Cancer Institute, Boston
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Toborzás folyamatban2. fázis
- Brigham and Women's Hospital, Boston
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Toborzás folyamatban2. fázis
- Brigham and Women's Hospital, Boston
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Toborzás folyamatban3. fázis
- Massachusetts General Hospital Cancer Center, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital Cancer Center, Boston
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Toborzás folyamatban1/2. fázis
- Brigham and Women's Hospital, Boston
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Toborzás folyamatban2/3. fázis
- Local Institution - 0195, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Toborzás folyamatban2. fázis
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Toborzás folyamatban3. fázis
- Research Site, Boston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
- Brigham & Women's Hospital, Boston
- Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
- és további 2
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Toborzás folyamatbanMegfigyeléses tanulmány
- Dana-Farber Cancer Institute, Boston
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Toborzás folyamatban
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Sacituzumab Govitecan Plus EV in Metastatic UC
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute, Boston
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Toborzás folyamatban
- Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Toborzás folyamatban3. fázis
- Brigham and Women's Hospital, Boston
Hólyagrák vizsgálatok más városokban
- New York City, NY35 tanulmány
- Nashville, TN31 tanulmány
- Houston, TX31 tanulmány
- Dallas, TX27 tanulmány
- Washington, DC26 tanulmány
- Los Angeles, CA24 tanulmány
- Baltimore, MD24 tanulmány
- St. Louis, MO22 tanulmány
- Philadelphia, PA21 tanulmány
- Seattle, WA21 tanulmány
- Edison, NJ21 tanulmány
- Chicago, IL21 tanulmány
Egyéb vizsgálatok: Boston
- Mellrák111 tanulmány
- Nem kis sejtes tüdőrák90 tanulmány
- Rák (minden típus)86 tanulmány
- Kolorektális rák63 tanulmány
- Áttétes rák63 tanulmány
- Tüdőrák62 tanulmány
- Petefészekrák61 tanulmány
- Prosztatarák59 tanulmány
- Depresszió52 tanulmány
- Endometriális rák50 tanulmány
- Szívelégtelenség44 tanulmány
- Akut mieloid leukémia44 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 5.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.